Genus plc (GENSF) Stock Competitors & Peer Comparison
See (GENSF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GENSF | $35.00 | +12.67% | 2.3B | 36.84 | $0.95 | +1.24% |
| NONOF | $42.11 | +2.09% | 183.6B | 9.70 | $4.26 | +4.33% |
| CSLLY | $18.15 | +6.26% | 67.3B | 11.28 | $1.54 | +4.15% |
| UCBJY | $153.07 | +1.94% | 57.8B | 32.50 | $4.67 | +0.56% |
| UCBJF | $310.09 | +6.14% | 56B | 31.56 | $9.32 | +0.58% |
| ARGNF | $885.00 | +5.99% | 54.8B | 39.26 | $22.54 | N/A |
| CMXHF | $71.00 | +0.48% | 32.4B | 10.95 | $6.17 | +4.32% |
| WXIBF | $4.40 | +0.00% | 18.2B | 25.88 | $0.17 | N/A |
| IVBXF | $9.10 | +0.00% | 15.8B | 130.00 | $0.07 | N/A |
| WXXWY | $7.59 | -2.44% | 15.7B | 22.34 | $0.34 | N/A |
Stock Comparison
GENSF vs NONOF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, NONOF has a market cap of 183.6B. Regarding current trading prices, GENSF is priced at $35.00, while NONOF trades at $42.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas NONOF's P/E ratio is 9.70. In terms of profitability, GENSF's ROE is +0.10%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, GENSF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check NONOF's competition here
GENSF vs CSLLY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CSLLY has a market cap of 67.3B. Regarding current trading prices, GENSF is priced at $35.00, while CSLLY trades at $18.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CSLLY's P/E ratio is 11.28. In terms of profitability, GENSF's ROE is +0.10%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, GENSF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check CSLLY's competition here
GENSF vs UCBJY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, UCBJY has a market cap of 57.8B. Regarding current trading prices, GENSF is priced at $35.00, while UCBJY trades at $153.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas UCBJY's P/E ratio is 32.50. In terms of profitability, GENSF's ROE is +0.10%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, GENSF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check UCBJY's competition here
GENSF vs UCBJF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, UCBJF has a market cap of 56B. Regarding current trading prices, GENSF is priced at $35.00, while UCBJF trades at $310.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas UCBJF's P/E ratio is 31.56. In terms of profitability, GENSF's ROE is +0.10%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, GENSF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check UCBJF's competition here
GENSF vs ARGNF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ARGNF has a market cap of 54.8B. Regarding current trading prices, GENSF is priced at $35.00, while ARGNF trades at $885.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ARGNF's P/E ratio is 39.26. In terms of profitability, GENSF's ROE is +0.10%, compared to ARGNF's ROE of +0.23%. Regarding short-term risk, GENSF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
GENSF vs CMXHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CMXHF has a market cap of 32.4B. Regarding current trading prices, GENSF is priced at $35.00, while CMXHF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CMXHF's P/E ratio is 10.95. In terms of profitability, GENSF's ROE is +0.10%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, GENSF and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
GENSF vs WXIBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, WXIBF has a market cap of 18.2B. Regarding current trading prices, GENSF is priced at $35.00, while WXIBF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas WXIBF's P/E ratio is 25.88. In terms of profitability, GENSF's ROE is +0.10%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, GENSF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
GENSF vs IVBXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, IVBXF has a market cap of 15.8B. Regarding current trading prices, GENSF is priced at $35.00, while IVBXF trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas IVBXF's P/E ratio is 130.00. In terms of profitability, GENSF's ROE is +0.10%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, GENSF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
GENSF vs WXXWY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, WXXWY has a market cap of 15.7B. Regarding current trading prices, GENSF is priced at $35.00, while WXXWY trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas WXXWY's P/E ratio is 22.34. In terms of profitability, GENSF's ROE is +0.10%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, GENSF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check WXXWY's competition here
GENSF vs GNMSF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, GNMSF has a market cap of 15.3B. Regarding current trading prices, GENSF is priced at $35.00, while GNMSF trades at $249.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas GNMSF's P/E ratio is 18.94. In terms of profitability, GENSF's ROE is +0.10%, compared to GNMSF's ROE of +0.15%. Regarding short-term risk, GENSF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check GNMSF's competition here
GENSF vs SBMFF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SBMFF has a market cap of 11.3B. Regarding current trading prices, GENSF is priced at $35.00, while SBMFF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SBMFF's P/E ratio is 21.10. In terms of profitability, GENSF's ROE is +0.10%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, GENSF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
GENSF vs SBHMY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SBHMY has a market cap of 10.7B. Regarding current trading prices, GENSF is priced at $35.00, while SBHMY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SBHMY's P/E ratio is 31.67. In terms of profitability, GENSF's ROE is +0.10%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, GENSF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
GENSF vs BRRGF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, GENSF is priced at $35.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, GENSF's ROE is +0.10%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, GENSF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check BRRGF's competition here
GENSF vs AAVXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, AAVXF has a market cap of 8.1B. Regarding current trading prices, GENSF is priced at $35.00, while AAVXF trades at $101.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas AAVXF's P/E ratio is -18.89. In terms of profitability, GENSF's ROE is +0.10%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, GENSF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
GENSF vs ODTC Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, GENSF is priced at $35.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ODTC's P/E ratio is 1.07. In terms of profitability, GENSF's ROE is +0.10%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, GENSF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
GENSF vs AKBLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, GENSF is priced at $35.00, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas AKBLF's P/E ratio is 34.83. In terms of profitability, GENSF's ROE is +0.10%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, GENSF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
GENSF vs REGMF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, GENSF is priced at $35.00, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas REGMF's P/E ratio is 51.63. In terms of profitability, GENSF's ROE is +0.10%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, GENSF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
GENSF vs ABCZF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, GENSF is priced at $35.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, GENSF's ROE is +0.10%, compared to ABCZF's ROE of +0.22%. Regarding short-term risk, GENSF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
GENSF vs TRSBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, TRSBF has a market cap of 5B. Regarding current trading prices, GENSF is priced at $35.00, while TRSBF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas TRSBF's P/E ratio is 3.92. In terms of profitability, GENSF's ROE is +0.10%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, GENSF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
GENSF vs SHJBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, GENSF is priced at $35.00, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, GENSF's ROE is +0.10%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, GENSF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check SHJBF's competition here
GENSF vs GNNSF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, GNNSF has a market cap of 3.5B. Regarding current trading prices, GENSF is priced at $35.00, while GNNSF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas GNNSF's P/E ratio is -6.40. In terms of profitability, GENSF's ROE is +0.10%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, GENSF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
GENSF vs TLPPF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, TLPPF has a market cap of 3.2B. Regarding current trading prices, GENSF is priced at $35.00, while TLPPF trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas TLPPF's P/E ratio is -470.50. In terms of profitability, GENSF's ROE is +0.10%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, GENSF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check TLPPF's competition here
GENSF vs BRCTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BRCTF has a market cap of 3.1B. Regarding current trading prices, GENSF is priced at $35.00, while BRCTF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BRCTF's P/E ratio is 140.00. In terms of profitability, GENSF's ROE is +0.10%, compared to BRCTF's ROE of +0.10%. Regarding short-term risk, GENSF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
GENSF vs INCPF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, GENSF is priced at $35.00, while INCPF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas INCPF's P/E ratio is 34.17. In terms of profitability, GENSF's ROE is +0.10%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, GENSF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
GENSF vs ZLDPF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ZLDPF has a market cap of 3B. Regarding current trading prices, GENSF is priced at $35.00, while ZLDPF trades at $42.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ZLDPF's P/E ratio is 3.03. In terms of profitability, GENSF's ROE is +0.10%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, GENSF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check ZLDPF's competition here
GENSF vs MPSYF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, GENSF is priced at $35.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, GENSF's ROE is +0.10%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, GENSF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check MPSYF's competition here
GENSF vs BVNRY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BVNRY has a market cap of 2.2B. Regarding current trading prices, GENSF is priced at $35.00, while BVNRY trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BVNRY's P/E ratio is 11.92. In terms of profitability, GENSF's ROE is +0.10%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, GENSF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check BVNRY's competition here
GENSF vs BVNKF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, GENSF is priced at $35.00, while BVNKF trades at $27.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BVNKF's P/E ratio is 11.84. In terms of profitability, GENSF's ROE is +0.10%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, GENSF and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
GENSF vs MEOBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, GENSF is priced at $35.00, while MEOBF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MEOBF's P/E ratio is -22.14. In terms of profitability, GENSF's ROE is +0.10%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, GENSF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
GENSF vs GLPGF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, GENSF is priced at $35.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, GENSF's ROE is +0.10%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, GENSF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
GENSF vs PHMMF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, GENSF is priced at $35.00, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, GENSF's ROE is +0.10%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, GENSF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
GENSF vs ASPHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ASPHF has a market cap of 1.7B. Regarding current trading prices, GENSF is priced at $35.00, while ASPHF trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ASPHF's P/E ratio is -8.71. In terms of profitability, GENSF's ROE is +0.10%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, GENSF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
GENSF vs ONTTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, GENSF is priced at $35.00, while ONTTF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ONTTF's P/E ratio is -8.60. In terms of profitability, GENSF's ROE is +0.10%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, GENSF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check ONTTF's competition here
GENSF vs BIESF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, GENSF is priced at $35.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BIESF's P/E ratio is -44.44. In terms of profitability, GENSF's ROE is +0.10%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, GENSF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
GENSF vs IDRSF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, IDRSF has a market cap of 1.5B. Regarding current trading prices, GENSF is priced at $35.00, while IDRSF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas IDRSF's P/E ratio is -4.42. In terms of profitability, GENSF's ROE is +0.10%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, GENSF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
GENSF vs ASCLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ASCLF has a market cap of 1.4B. Regarding current trading prices, GENSF is priced at $35.00, while ASCLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ASCLF's P/E ratio is -27.00. In terms of profitability, GENSF's ROE is +0.10%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, GENSF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
GENSF vs HBMHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, GENSF is priced at $35.00, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, GENSF's ROE is +0.10%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, GENSF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
GENSF vs SNBIF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, GENSF is priced at $35.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, GENSF's ROE is +0.10%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, GENSF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check SNBIF's competition here
GENSF vs MDCLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, GENSF is priced at $35.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, GENSF's ROE is +0.10%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, GENSF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
GENSF vs NURPF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, NURPF has a market cap of 1.2B. Regarding current trading prices, GENSF is priced at $35.00, while NURPF trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas NURPF's P/E ratio is 57.81. In terms of profitability, GENSF's ROE is +0.10%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, GENSF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
GENSF vs CSPHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CSPHF has a market cap of 1.1B. Regarding current trading prices, GENSF is priced at $35.00, while CSPHF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CSPHF's P/E ratio is -13.90. In terms of profitability, GENSF's ROE is +0.10%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, GENSF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check CSPHF's competition here
GENSF vs CSBTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CSBTF has a market cap of 1B. Regarding current trading prices, GENSF is priced at $35.00, while CSBTF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CSBTF's P/E ratio is 325.00. In terms of profitability, GENSF's ROE is +0.10%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, GENSF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check CSBTF's competition here
GENSF vs BTTAY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, GENSF is priced at $35.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, GENSF's ROE is +0.10%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, GENSF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check BTTAY's competition here
GENSF vs TKBIF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, GENSF is priced at $35.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas TKBIF's P/E ratio is -14.60. In terms of profitability, GENSF's ROE is +0.10%, compared to TKBIF's ROE of N/A. Regarding short-term risk, GENSF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check TKBIF's competition here
GENSF vs PHGUF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PHGUF has a market cap of 872.9M. Regarding current trading prices, GENSF is priced at $35.00, while PHGUF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PHGUF's P/E ratio is 61.80. In terms of profitability, GENSF's ROE is +0.10%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, GENSF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check PHGUF's competition here
GENSF vs PPTDF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PPTDF has a market cap of 828.8M. Regarding current trading prices, GENSF is priced at $35.00, while PPTDF trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PPTDF's P/E ratio is -35.83. In terms of profitability, GENSF's ROE is +0.10%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, GENSF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check PPTDF's competition here
GENSF vs BPMUF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BPMUF has a market cap of 805.6M. Regarding current trading prices, GENSF is priced at $35.00, while BPMUF trades at $65.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BPMUF's P/E ratio is 9.14. In terms of profitability, GENSF's ROE is +0.10%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, GENSF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
GENSF vs CKDXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, GENSF is priced at $35.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, GENSF's ROE is +0.10%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, GENSF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check CKDXF's competition here
GENSF vs SOLTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SOLTF has a market cap of 559.6M. Regarding current trading prices, GENSF is priced at $35.00, while SOLTF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SOLTF's P/E ratio is -7.01. In terms of profitability, GENSF's ROE is +0.10%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, GENSF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
GENSF vs IVEVF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, IVEVF has a market cap of 556.2M. Regarding current trading prices, GENSF is priced at $35.00, while IVEVF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas IVEVF's P/E ratio is -1.81. In terms of profitability, GENSF's ROE is +0.10%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, GENSF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
GENSF vs INRLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, INRLF has a market cap of 519.6M. Regarding current trading prices, GENSF is priced at $35.00, while INRLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas INRLF's P/E ratio is -2.95. In terms of profitability, GENSF's ROE is +0.10%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, GENSF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
GENSF vs GNFTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, GNFTF has a market cap of 475.8M. Regarding current trading prices, GENSF is priced at $35.00, while GNFTF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas GNFTF's P/E ratio is -4.75. In terms of profitability, GENSF's ROE is +0.10%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, GENSF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check GNFTF's competition here
GENSF vs RAONF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, GENSF is priced at $35.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas RAONF's P/E ratio is -43.33. In terms of profitability, GENSF's ROE is +0.10%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, GENSF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check RAONF's competition here
GENSF vs GNFTY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, GENSF is priced at $35.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, GENSF's ROE is +0.10%, compared to GNFTY's ROE of -0.65%. Regarding short-term risk, GENSF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check GNFTY's competition here
GENSF vs PTCHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PTCHF has a market cap of 438.2M. Regarding current trading prices, GENSF is priced at $35.00, while PTCHF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PTCHF's P/E ratio is -3.91. In terms of profitability, GENSF's ROE is +0.10%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, GENSF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
GENSF vs AVCTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, AVCTF has a market cap of 437.4M. Regarding current trading prices, GENSF is priced at $35.00, while AVCTF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas AVCTF's P/E ratio is -8.33. In terms of profitability, GENSF's ROE is +0.10%, compared to AVCTF's ROE of -29.83%. Regarding short-term risk, GENSF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
GENSF vs BOVNF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, GENSF is priced at $35.00, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, GENSF's ROE is +0.10%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, GENSF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check BOVNF's competition here
GENSF vs TBGNF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, GENSF is priced at $35.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, GENSF's ROE is +0.10%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, GENSF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
GENSF vs NWPHF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, GENSF is priced at $35.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas NWPHF's P/E ratio is -26.32. In terms of profitability, GENSF's ROE is +0.10%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, GENSF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check NWPHF's competition here
GENSF vs CYDY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CYDY has a market cap of 405.4M. Regarding current trading prices, GENSF is priced at $35.00, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CYDY's P/E ratio is -7.40. In terms of profitability, GENSF's ROE is +0.10%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, GENSF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check CYDY's competition here
GENSF vs SPHDF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, GENSF is priced at $35.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SPHDF's P/E ratio is -4.86. In terms of profitability, GENSF's ROE is +0.10%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, GENSF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check SPHDF's competition here
GENSF vs SCNLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SCNLF has a market cap of 325.2M. Regarding current trading prices, GENSF is priced at $35.00, while SCNLF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SCNLF's P/E ratio is -31.34. In terms of profitability, GENSF's ROE is +0.10%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, GENSF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
GENSF vs CLVLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CLVLF has a market cap of 322.6M. Regarding current trading prices, GENSF is priced at $35.00, while CLVLF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CLVLF's P/E ratio is 14.22. In terms of profitability, GENSF's ROE is +0.10%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, GENSF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
GENSF vs CLVLY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CLVLY has a market cap of 320.6M. Regarding current trading prices, GENSF is priced at $35.00, while CLVLY trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CLVLY's P/E ratio is 14.13. In terms of profitability, GENSF's ROE is +0.10%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, GENSF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
GENSF vs NWBO Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, NWBO has a market cap of 317.6M. Regarding current trading prices, GENSF is priced at $35.00, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas NWBO's P/E ratio is -6.44. In terms of profitability, GENSF's ROE is +0.10%, compared to NWBO's ROE of +0.62%. Regarding short-term risk, GENSF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check NWBO's competition here
GENSF vs VBIZF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, VBIZF has a market cap of 316.7M. Regarding current trading prices, GENSF is priced at $35.00, while VBIZF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas VBIZF's P/E ratio is 15.00. In terms of profitability, GENSF's ROE is +0.10%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, GENSF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
GENSF vs NGENF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, GENSF is priced at $35.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas NGENF's P/E ratio is -15.19. In terms of profitability, GENSF's ROE is +0.10%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, GENSF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check NGENF's competition here
GENSF vs FGHQF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, GENSF is priced at $35.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, GENSF's ROE is +0.10%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, GENSF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
GENSF vs HLOSF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, HLOSF has a market cap of 290.7M. Regarding current trading prices, GENSF is priced at $35.00, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas HLOSF's P/E ratio is -15.88. In terms of profitability, GENSF's ROE is +0.10%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, GENSF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
GENSF vs PBBIF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, GENSF is priced at $35.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, GENSF's ROE is +0.10%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, GENSF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
GENSF vs KNTPF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, KNTPF has a market cap of 265M. Regarding current trading prices, GENSF is priced at $35.00, while KNTPF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas KNTPF's P/E ratio is -8.07. In terms of profitability, GENSF's ROE is +0.10%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, GENSF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
GENSF vs CMVLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, CMVLF has a market cap of 251M. Regarding current trading prices, GENSF is priced at $35.00, while CMVLF trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas CMVLF's P/E ratio is -10.52. In terms of profitability, GENSF's ROE is +0.10%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, GENSF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
GENSF vs HNSBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, GENSF is priced at $35.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas HNSBF's P/E ratio is -3.45. In terms of profitability, GENSF's ROE is +0.10%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, GENSF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check HNSBF's competition here
GENSF vs OPORF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, GENSF is priced at $35.00, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas OPORF's P/E ratio is 35.00. In terms of profitability, GENSF's ROE is +0.10%, compared to OPORF's ROE of -0.15%. Regarding short-term risk, GENSF and OPORF have similar daily volatility (0.00).Check OPORF's competition here
GENSF vs ORYZF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, GENSF is priced at $35.00, while ORYZF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ORYZF's P/E ratio is -101.00. In terms of profitability, GENSF's ROE is +0.10%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, GENSF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
GENSF vs SPHRF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SPHRF has a market cap of 227.3M. Regarding current trading prices, GENSF is priced at $35.00, while SPHRF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SPHRF's P/E ratio is -54.00. In terms of profitability, GENSF's ROE is +0.10%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, GENSF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
GENSF vs SPHRY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SPHRY has a market cap of 214.7M. Regarding current trading prices, GENSF is priced at $35.00, while SPHRY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SPHRY's P/E ratio is -85.00. In terms of profitability, GENSF's ROE is +0.10%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, GENSF is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check SPHRY's competition here
GENSF vs IPHYF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, IPHYF has a market cap of 211.3M. Regarding current trading prices, GENSF is priced at $35.00, while IPHYF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas IPHYF's P/E ratio is -3.52. In terms of profitability, GENSF's ROE is +0.10%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, GENSF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check IPHYF's competition here
GENSF vs FPHAF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, GENSF is priced at $35.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, GENSF's ROE is +0.10%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, GENSF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
GENSF vs RECEF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, GENSF is priced at $35.00, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas RECEF's P/E ratio is -8.33. In terms of profitability, GENSF's ROE is +0.10%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, GENSF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check RECEF's competition here
GENSF vs PHCUF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PHCUF has a market cap of 176.4M. Regarding current trading prices, GENSF is priced at $35.00, while PHCUF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PHCUF's P/E ratio is 19.50. In terms of profitability, GENSF's ROE is +0.10%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, GENSF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
GENSF vs ADOCY Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, GENSF is priced at $35.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, GENSF's ROE is +0.10%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, GENSF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
GENSF vs BBIXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, GENSF is priced at $35.00, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, GENSF's ROE is +0.10%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, GENSF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check BBIXF's competition here
GENSF vs SLNCF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, SLNCF has a market cap of 150.2M. Regarding current trading prices, GENSF is priced at $35.00, while SLNCF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas SLNCF's P/E ratio is -1.96. In terms of profitability, GENSF's ROE is +0.10%, compared to SLNCF's ROE of -1.22%. Regarding short-term risk, GENSF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
GENSF vs JWCTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, JWCTF has a market cap of 147.9M. Regarding current trading prices, GENSF is priced at $35.00, while JWCTF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas JWCTF's P/E ratio is -1.78. In terms of profitability, GENSF's ROE is +0.10%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, GENSF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check JWCTF's competition here
GENSF vs AMGXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, GENSF is priced at $35.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, GENSF's ROE is +0.10%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, GENSF and AMGXF have similar daily volatility (0.00).Check AMGXF's competition here
GENSF vs HBPCF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, GENSF is priced at $35.00, while HBPCF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, GENSF's ROE is +0.10%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, GENSF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
GENSF vs AAPGV Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, GENSF is priced at $35.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas AAPGV's P/E ratio is N/A. In terms of profitability, GENSF's ROE is +0.10%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, GENSF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check AAPGV's competition here
GENSF vs TRGNF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, GENSF is priced at $35.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, GENSF's ROE is +0.10%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, GENSF and TRGNF have similar daily volatility (0.00).Check TRGNF's competition here
GENSF vs PSTTF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, GENSF is priced at $35.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, GENSF's ROE is +0.10%, compared to PSTTF's ROE of N/A. Regarding short-term risk, GENSF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
GENSF vs ATGGF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ATGGF has a market cap of 113.4M. Regarding current trading prices, GENSF is priced at $35.00, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ATGGF's P/E ratio is N/A. In terms of profitability, GENSF's ROE is +0.10%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, GENSF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check ATGGF's competition here
GENSF vs EPRXF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, GENSF is priced at $35.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, GENSF's ROE is +0.10%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, GENSF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check EPRXF's competition here
GENSF vs BRIBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, BRIBF has a market cap of 107.8M. Regarding current trading prices, GENSF is priced at $35.00, while BRIBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas BRIBF's P/E ratio is -3.74. In terms of profitability, GENSF's ROE is +0.10%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, GENSF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
GENSF vs ADOIF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, GENSF is priced at $35.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, GENSF's ROE is +0.10%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, GENSF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
GENSF vs ORPOF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, ORPOF has a market cap of 99.4M. Regarding current trading prices, GENSF is priced at $35.00, while ORPOF trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas ORPOF's P/E ratio is -4.53. In terms of profitability, GENSF's ROE is +0.10%, compared to ORPOF's ROE of N/A. Regarding short-term risk, GENSF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
GENSF vs MSCLF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, GENSF is priced at $35.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, GENSF's ROE is +0.10%, compared to MSCLF's ROE of -0.61%. Regarding short-term risk, GENSF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check MSCLF's competition here
GENSF vs MLLCF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MLLCF has a market cap of 95.7M. Regarding current trading prices, GENSF is priced at $35.00, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MLLCF's P/E ratio is -1.30. In terms of profitability, GENSF's ROE is +0.10%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, GENSF and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
GENSF vs MCURF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, GENSF is priced at $35.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas MCURF's P/E ratio is -16.90. In terms of profitability, GENSF's ROE is +0.10%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, GENSF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for GENSF.Check MCURF's competition here
GENSF vs POLBF Comparison June 2026
GENSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GENSF stands at 2.3B. In comparison, POLBF has a market cap of 81.4M. Regarding current trading prices, GENSF is priced at $35.00, while POLBF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GENSF currently has a P/E ratio of 36.84, whereas POLBF's P/E ratio is -11.54. In terms of profitability, GENSF's ROE is +0.10%, compared to POLBF's ROE of -0.55%. Regarding short-term risk, GENSF and POLBF have similar daily volatility (0.00).Check POLBF's competition here